(Press-News.org) The Gabriella Miller Kids First Pediatric Research Program (Kids First) has released its 36th study and introduced significant new data updates to two existing studies, further advancing efforts to uncover the genetic foundations of childhood cancers and congenital conditions. This brings the total data files available at the Kids First Data Resource Center (Kids First DRC) to more than 110,000.
WHO: Kids First, a program from the National Institutes of Health (NIH)
WHAT: Announcing the latest data releases to the Kids First data ecosystem. Newly released and updated datasets are available publicly, including:
CONGENITAL CONDITIONS
Kids First: Whole Genome Sequencing Studies of Multiplex Nonsyndromic Cleft Lip/Palate Families (KF-MNC)
Apply via dbGaP: phs002626
Principal Investigator: Ariadne M. Letra, PhD, University of Pittsburgh
This new study, Kids First’s 36th, explores nonsyndromic cleft lip/palate, a condition that accounts for 65% of all congenital anomalies. Short-read whole-genome sequencing (WGS) data from 828 participants in 168 multigenerational families are now available.
Kids First: Congenital Diaphragmatic Hernia (KF-CDH)
Apply via dbGaP: phs001110
Principal Investigator: Wendy Chung, MD, PhD, Columbia University Medical Center
This longstanding study received a major data update: over 1,600 new participants, 2,100 samples, and additional modalities including RNA-Seq and PacBio long-read sequencing. Congenital diaphragmatic hernia is one of the most common and lethal congenital anomalies, affecting 1 in 3,000 live births.
CHILDHOOD CANCERS
Kids First: T-cell Acute Lymphoblastic Leukemia (KF-TALL)
Apply via dbGaP: phs002276
Principal Investigator: David T. Teachey, MD, Children’s Hospital of Philadelphia
A small update adds 2 new RNA-Seq samples. This study seeks to improve risk stratification and identify genetic drivers of relapse and treatment toxicity in pediatric T-ALL.
WHEN: All datasets are available now.
WHERE: Access and explore these new data through the Kids First Data Resource Portal. Instructions for requesting access to controlled data are available in the Kids First Help Center.
WHY: By releasing high-quality genomic data from children and families affected by pediatric cancers and congenital conditions, Kids First empowers researchers everywhere to uncover new diagnostic markers, therapeutic targets, and disease risk factors. This publicly available resource promotes data sharing and collaborative discovery that could lead to life-changing treatments for children.
About the Gabriella Miller Kids First Data Resource Center (Kids First DRC)
Kids First DRC, part of the NIH Common Fund Gabriella Miller Kids First Pediatric Research Program, is a centralized, open-access, cloud-based platform that enables pediatric researchers to study the genetic links between childhood cancers and congenital conditions. It supports a global community of scientists, clinicians, and patient families working together to accelerate cures for children. Learn more at kidsfirstdrc.org.
Press Contact
Whitney Rife
rifew@chop.edu
END
New study and major data updates expand the Kids First data ecosystem
The Gabriella Miller Kids First Pediatric Research Program has released its 36th study and introduced significant new data updates to two existing studies, further advancing efforts to uncover the genetic foundations of childhood cancer
2025-09-08
ELSE PRESS RELEASES FROM THIS DATE:
Seaweed snare: Sargassum stops sea turtle hatchlings in their tracks
2025-09-08
Every year, sea turtles hatch on Florida’s beaches and make their way from the sand to the ocean – a critical journey that determines their chances of survival. As these hatchlings navigate obstacles such as artificial lights, beach debris and predators like birds and crabs, a new hazard looms. Sargassum seaweed washing up on Florida’s shores in record amounts is more than just a nuisance for beachgoers – it’s becoming a serious threat to vulnerable sea turtle hatchlings.
While it’s long been known that obstacles on the beach can slow down hatchlings and put ...
Scientists uncover key to decoupling economic growth from pollution in developing countries
2025-09-08
Balancing environmental conservation with economic progress is one of the most pressing challenges of our time. This is particularly difficult for many developing countries, which urgently need to lift their populations out of poverty while grappling with the increasing degradation of their environment. Unfortunately, a common belief is that these nations have to choose between economic growth and a clean environment—a situation made more complex by their reliance on foreign aid.
While the United Nations Sustainable Development Goals provide a global roadmap for tackling such issues, ...
Frailty fuels gut imbalance and post-surgery gastrointestinal risks
2025-09-08
Gastrointestinal (GI) complications, such as postoperative ileus (POI) and intra-abdominal infections (IAI), remain a major concern after radical cystectomy for bladder cancer. Even with advances in surgical techniques, including robot-assisted radical cystectomy with intracorporeal urinary diversion (iRARC), and the adoption of enhanced recovery protocols, these complications continue to affect a substantial proportion of patients. They not only prolong hospital stays but also increase patient morbidity, underscoring the need to identify risk factors beyond surgical technique alone.
In a new study ...
BMS-986504 demonstrates durable responses in MTAP-deleted NSCLC, including EGFR and ALK-positive tumors
2025-09-08
Barcelona, Spain (September 8, 2025, Noon CEST / UTC +2 ) — BMS-986504, a first-in-class methylthioadenosine (MTA)-cooperative protein arginine methyltransferase 5 (PRMT5) targeting agent, showed promising antitumor activity in heavily pretreated patients with MTAP-deleted non-small cell lung cancer (NSCLC), according to results from the Phase 1CA240-0007 trial presented at the International Association for the Study of Lung Cancer 2025 World Conference on Lung Cancer (WCLC).
MTAP, encoding the enzyme methylthioadenosine phosphorylase, is ...
Phase III trial finds hypofractionated radiotherapy with chemotherapy offers comparable survival and lower toxicity to conventional schedule in LS-SCLC
2025-09-08
(Barcelona, Spain September 8, 2025, 10:45 a.m. CEST / UTC +2) ) — A multi-center, randomized phase III trial has found that a three-week hypofractionated radiotherapy (HypoRT) schedule with concurrent chemotherapy provides similar survival outcomes and reduced toxicity compared to the standard six-week conventional fractionated radiotherapy (ConvRT) schedule for patients with limited-stage small cell lung cancer (LS-SCLC).
The results were presented today at the International Association for the Study of Lung Cancer (IASLC) 2025 World Conference on Lung Cancer (WCLC).
In hypofractionated ...
Lung cancer screening benefits adults up to age 80 if surgical candidates, UK study finds
2025-09-08
(Barcelona, Spain September 8, 2025, 10:45 a.m. CEST / UTC +2) Older individuals between the ages of 75 and 80 who are eligible for lung surgery may achieve survival outcomes comparable to younger patients following lung cancer screening, according to research presented today at the International Association for the Study of Lung Cancer (IASLC) 2025 World Conference on Lung Cancer (WCLC).
Despite half of lung cancers being diagnosed in people aged 75 or older, randomized evidence on screening outcomes in this age group is limited. Most national lung cancer screening programs, including the UK’s, stop at age 74. The U.S. Preventive ...
Video assisted thoracoscopy surgery reduces mortality by 21 percent compared to lobectomy
2025-09-08
(Barcelona, Spain September 8, 2025, 10:45 a.m. CEST / UTC +2) – Patients who underwent video-assisted thoracoscopic surgery (VATS) compared to open lobectomy had a significantly improved overall survival rate, according to a meta-analysis presented at the International Association for the Study of Lung Cancer (IASLC) 2025 World Conference on Lung Cancer (WCLC).
Video-assisted thoracoscopic surgery (VATS) is currently the most common approach to perform pulmonary lobectomy in early-stage lung cancer. Advantages include reduced pain, fewer complications, faster recovery and improved quality-of-life. The adoption of VATS lobectomy ...
NADIM ADJUVANT trial suggests benefit of adjuvant chemo-immunotherapy in resected stage IB–IIIA NSCLC
2025-09-08
(Barcelona, Spain September 8, 2025, 10:45 a.m. CEST / UTC +2) – Interim results from the NADIM ADJUVANT Phase III trial, led by the Spanish Lung Cancer Group (GECP), suggest that adjuvant chemo-immunotherapy may reduce the risk of recurrence in patients with completely resected stage IB–IIIA non-small cell lung cancer (NSCLC) while maintaining an acceptable safety profile.
Despite complete surgical resection (R0), early-stage NSCLC carries a substantial risk of recurrence and remains a leading cause of cancer-related ...
EA5181 phase 3 trial finds no OS benefit for concurrent and consolidative durvalumab vs consolidation alone in unresectable stage 3 NSCLC
2025-09-08
(Barcelona, Spain September 8, 2025, 10:45 a.m. CEST / UTC +2) — Treating patients who have stage III non-small cell lung cancer (NSCLC) with durvalumab concurrent with chemoradiotherapy (CRT) and continuing as consolidation therapy did not improve overall survival compared to consolidation durvalumab alone, according to research presented today at the International Association for the Study of Lung Cancer (IASLC) 2025 World Conference on Lung Cancer (WCLC).
Consolidation durvalumab improves survival ...
Training to improve memory
2025-09-08
In Europe, almost one in 10 people over 70 suffers from dementia, and this figure could even triple by 2050 due to rising life expectancy. Over time, those affected lose everything that makes them who they are, including their memory and their ability to go about their everyday lives. Many also suffer from physical deterioration. In an advanced stage of the disorder, dementia patients generally require comprehensive care.
Now, the first drugs have emerged that can slightly slow down disease progression in the early stages of Alzheimer’s – ...
LAST 30 PRESS RELEASES:
Scientists create ChatGPT-like AI model for neuroscience to build one of the most detailed mouse brain maps to date
AI and omics unlock personalized drugs and RNA therapies for heart disease
2023 ocean heatwave ‘unprecedented but not unexpected’
Johns Hopkins researchers develop AI to predict risk of US car crashes
New drug combination offers hope for men with advanced prostate cancer
New discovery finds gene converts insulin-producing cells into blood-sugar boosters
Powerful and precise multi-color lasers now fit on a single chip
Scientists agree chemicals can affect behavior, but industry workers more reluctant about safety testing
DNA nanospring measures cellular motor power
Elsevier Foundation and RIKEN launch “Envisioning Futures” report: paving the way for gender equity and women’s leadership in Japanese research
Researchers discover enlarged areas of the spinal cord in fish, previously found only in four-limbed vertebrates
Bipolar disorder heterogeneity decoded: transforming global psychiatric treatment approaches
Catching Alport syndrome through universal age-3 urine screening
Instructions help you remember something better than emotions or a good night’s sleep
Solar energy is now the world’s cheapest source of power, a Surrey study finds
Scientists reverse Alzheimer’s in mice using nanoparticles
‘Good’ gut bacteria boosts placenta for healthier pregnancy
USC team demonstrates first optical device based on “optical thermodynamics”
Microplastics found to change gut microbiome in first human-sample study
Artificially sweetened and sugary drinks are both associated with an increased risk of liver disease, study finds
Plastic in the soil, but not as we know it: Biodegradable microplastics rewire carbon storage in farm fields
Yeast proteins reveal the secrets of drought resistance
Psychiatry, primary care, and OB/GYN subspecialties hit hardest by physician attrition
New Canadian study reveals where HIV hides in different parts of the body
Lidocaine poisonings rise despite overall drop in local anesthetic toxicity
Politics follow you on the road
Scientists blaze new path to fighting viral diseases
The mouse eye as a window to spotting systemic disease
AI and the Future of Cancer Research and Cancer Care to headline October 24 gathering of global oncology leaders at the National Press Club: NFCR Global Summit to feature top scientists, entrepreneurs
FDA clears UCLA heart tissue regeneration drug AD-NP1 for clinical trials
[Press-News.org] New study and major data updates expand the Kids First data ecosystemThe Gabriella Miller Kids First Pediatric Research Program has released its 36th study and introduced significant new data updates to two existing studies, further advancing efforts to uncover the genetic foundations of childhood cancer